Advances in prevention and health services delivery 2007

Stroke

Volumn 39, Issue 2, 2008, Pages 258-260

  Goldstein, Larry B ^a,c   Rothwell, Peter M ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Health care; Health services delivery; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; WARFARIN;

BLEEDING; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE DELIVERY; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; STROKE; TRANSIENT ISCHEMIC ATTACK; REVIEW; RISK FACTOR; STATISTICS;

DELIVERY OF HEALTH CARE; HUMANS; RISK FACTORS; STROKE;

EID: 39349094985     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.511501     Document Type: Short Survey

References (24)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke. 1991;22:983-988.
2. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262.
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
4. Rothwell PM. External validity of randomised controlled trials: "To whom do the results of this trial apply?". Lancet. 2005;365:82-93.
5. Hart RG, Pearce LA, Albers GW, Connolly SJ, Friday GH, Gage BF, Go AS, Goldstein LB, Gronseth G, Halperin JL, Hylek EM, Lip GYH, Sherman DG, Singer DE, van Walraven C. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology. 2007;69:546-554.
6. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy. Lancet. 1996;348:423-428.
7. Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004;141:745-752.
8. Sweeney KG, Gray DP, Steele R, Evans P. Use of warfarin in nonrheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract. 1995;45:153-158.
9. Marine JE, Goldhaber SZ. Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation. Chest. 1998;113:1115-1118.
10. Morgan SV. Between the devil and the deep blue sea - balancing the risks and potential benefits of warfarin for older people with atrial fibrillation. Age & Ageing. 2004;33:544-547.
11. Garcia-Honrubia A, Roldan V, Climent V, Sogorb F, Marin F. Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task. Int J Cardiol. 2006;110:271-272.
12. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, Moomaw CJ, Haverbusch M, Broderick JP. The increasing incidence of anticoagulant- associated intracerebral hemorrhage. Neurology. 2007;68:116-121.
13. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation. 2006;114:e257-e354.
14. Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age & Ageing. 2007;36:151-156.
15. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham atrial fibrillation treatment of the aged study, BAFTA): A randomised controlled trial. Lancet. 2007;370:493-503.
16. Easton JD, Albers GW, Caplan LR, Saver JL, Sherman DG. Reconsideration of TIA terminology and definitions. Neurology. 2004;62(suppl. 6):S29 -S34.
17. Goldstein LB, Bian J, Samsa GP, Bonito AJ, Lux LJ, Matchar DB. New TIA and stroke: Outpatient management by primary care physicians. Arch Intern Med. 2000;160:2941-2946.
18. Giles MF, Rothwell PM. Risk of stroke early after transient ischemic attack: a systematic review and meta-analysis. Lancet Neurology. 2007;6:1063-1072.
19. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283-292.
20. Koton S, Rothwell PM. Performance of the abcd and abcd2 scores in TIA patients with carotid stenosis and atrial fibrillation. Cerebrovascular Diseases. 2007;24:231-235.
21. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, Lovelock CE, Binney LE, Bull LM, Cuthbertson FC, Welch SJ, Bosch S, Carasco-Alexander F, Silver LE, Gutnikov SA, Mehta Z. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet. 2007;370:1432-1442.
22. Lavallee PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot P, Lapergue B, Klein IF, Brochet E, Steg PG, Leseche G, Labreuche J, Touboul PJ, Amarenco P. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurology. 2007;6:953-960.
23. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915-924.
24. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, for the FI. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurology. 2007;6:961-969.